Tencent has followed its series A investment in the comics and animated content producer last year by acquiring a majority share in the company.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Biocon's biosimilar subsidiary is valued at $3.5bn in the deal, which will involve Tata Capital acquiring a stake sized at under 1%.

Line’s on-demand delivery service has attracted $110m from BRV Capital as it merged with restaurant listings website Wongnai Media.

Heal has entered into a strategic partnership with Humana that includes a $100m investment from the corporate and will support an expansion into additional US cities.

Mitsui and Virgin-backed remittance service TransferWise has bolstered its valuation to $5bn, up from $3.5bn, through a $319m secondary share sale.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The real estate investment manager is now the largest investor in Harel Group-backed Ecoppia, which provides solar-panel cleaning systems.

GlaxoSmithKline is paying $176m for a 10% stake in the RNA drug developer in connection with a strategic partnership agreement.

The conglomerate has taken a majority stake in the Bharti Airtel and HT Media-backed news app developer through a primary and secondary deal.